Navigation Links
Acc in Medical Technology

RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009

FRANKLIN, Mass., March 27 /PRNewswire-FirstCall/ -- PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that the first data from its pilot safety trial for RenalGuard(R) will be presented in a poster ...

Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session

SAN MATEO¿ Calif.¿ March 23 /PRNewswire/ -- Results from the Phase II portion of a Phase II/III clinical trial of Corthera's investigational drug relaxin for the treatment of acute heart failure will be presented at 10:30 a.m. EDT on Sunday, March 29, at the American College of Cardiology's (ACC...

Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions

Results of Mouse Model of Diabetes with Haptoglobin 2-2 Genotype Show Modification of HDL Structure and Defective Reverse Cholesterol Transport MONTVALE, N.J., March 31 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI ) announces data from a study of diabetic mice with the H...

Media Advisory: ACC Updated Schedule

Schering-Plough Announces Presentation Of Phase II Trial Results For Novel Oral Thrombin Receptor Antagonist At The 2007 Annual Meeting Of The American College Of Cardiology/i2 Summit KENILWORTH, N.J., March 16, 2007 /PRNewswire-FirstCall/ -- Schering-Plough Corporation announced today that result...

Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2 Predicts Heart Disease Risk in Metabolic Syndrome Patients

NEW ORLEANS--(BUSINESS WIRE)--Mar 26, 2007 - Study results show that elevated lipoprotein-associated phospholipase A2 (Lp-PLA2), a cardiovascular-specific inflammatory enzyme associated with unstable plaque that can lead to heart attack and stroke, is especially predictive of heart disease risk in ...

Study Presented at ACC Shows Treatment With ISIS 301012 Added to Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C Levels of Less Than 70 mg/dL

* ISIS 301012 coadministered with statins for only five weeks at 400 mg/week lowered LDL-C 47% beyond the levels achieved with statins alone, with similarly favorable effects on other atherogenic lipids NEW ORLEANS and CARLSBAD, Calif., March 26, 2007 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals...

Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical Data for INO-1001 at ACC Demonstrating PARP Inhibition and Anti-inflammatory Activity in Plasma of Patients Undergoing Primary Percutaneous Coronary Intervention

BEVERLY, Mass.--(BUSINESS WIRE)--Mar 27, 2007 - Inotek Pharmaceuticals Corporation announced today the presentation of positive Phase 2 clinical data demonstrating the safety of INO-1001 as well as the potential for INO-1001 as a preventative agent for cardiac reperfusion injury. The study was cond...

Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients Presented at ACC

* Homozygous FH patients already being treated with maximally tolerated lipid-lowering therapies experienced 50% further reductions in LDL-C with similar reductions in other atherogenic when treated with 300 mg/week ISIS 301012 NEW ORLEANS, and CARLSBAD, Calif., March 26, 2007 /PRNewswire-FirstCal...

New Bisphenol A Study Is of Very Limited Relevance to Human Health

...g companies engaged in the business of chemistry. acc members apply the science of chemistry to make inn... make people's lives better, healthier and safer. acc is committed to improved environmental, health and... and security have always been primary concerns of acc members, and they have intensified their efforts, ...

Results From Study Show Promising Efficacy and Safety Results for Corthera's Relaxin in Acute Heart Failure

...sented at Late-Breaking Clinical Trials Session at acc 58th Annual Scientific Session; Results Published ...y results presented in this important forum at the acc and published in the prestigious journal The Lance... 858.717.2310 (mobile number while at acc Scientific Session) david.schull@...

Clinical Data Reinforce Safety and Efficacy of Boston Scientific's Two Drug- Eluting Stent Platforms

...r rates of Major Adverse Cardiac Events (MACE), the MACE results in patients with diabetes favored the TAXUS Stent. "Clinical data presented at acc continue to reinforce the value of Boston Scientific's two-drug portfolio," said Keith D. Dawkins, M.D., Associate Chief Medical Officer of Boston Sci...

American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time

...s evaluation and post-experience assessment. The acc is the nation's leader in promoting evidence-based...e D2B Alliance. W. Douglas Weaver, M.D., F.A.C.C., acc President, asserted that, "I am proud that the acc is collaborating with leaders in simulation techno...

Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use

... leading the way to optimal cardiovascular care and disease prevention. The acc is a 36,000-member nonprofit medical society and bestows the credential Fel... and guidelines, and is a staunch supporter of cardiovascular research. The acc provides professional education and operates national registries for the me...

New Bisphenol A Study Has Limited Capability to Assess Human Health Effects

...ng companies engaged in the business of chemistry. acc members apply the science of chemistry to make inn...t make people's lives better, healthier and safer. acc is committed to improved environmental, health and... and security have always been primary concerns of acc members, and they have intensified their efforts, ...

Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber

...ren (VO52) in phase III trials. "This study has demonstrated a clear consistency with the outcomes of previous pivotal studies. It opens the way for acc as a new tool for phase II studies reducing the unpredictability of pollination. Moreover, it confirms the therapeutic effect of Oralair(R) Grasses an...

MitraClip Device Preliminary Data Suggests Improved Heart Function and Relief from Heart Failure Symptoms in Functional Mitral Regurgitation Patients

...from the ongoing Endovascular Valve Edge-to-Edge REpair STudy (EVEREST) presented today at the SCAI Annual Scientific Sessions in Partnership with the acc i2 Summit (SCAI-ACCi2). The EVEREST trial is evaluating the safety and efficacy of the MitraClip device for the treatment of MR, a condition in which ...

Abbott's Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL

...guidelines endorsed by the National Cholesterol Education Panel (NCEP), the acc and the American Heart Association have called for more aggressive manageme...bout the TriLipix Clinical Program The two studies being presented at the acc conference are part of a broad clinical program to evaluate the efficacy an...

Abbott's XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years

...eluting coronary stent system. The two-year results from the SPIRIT II trial were presented at the SCAI Annual Scientific Sessions in Partnership with acc i2 Summit. SPIRIT II is a 300-patient randomized clinical trial, which was conducted in Europe and Asia Pacific to support the launch of XIENCE V ou...

SPIRIT II Explores Long-Term Performance of XIENCE V Stent

...l Trials session at the SCAI Annual Scientific Sessions in Partnership with acc i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for p... and guidelines, and is a staunch supporter of cardiovascular research. The acc provides professional education and operates national registries for the me...

Large Study Gives Nod to Drug-Eluting Stents in Heart Attack

...l Trials session at the SCAI Annual Scientific Sessions in Partnership with acc i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for p... and guidelines, and is a staunch supporter of cardiovascular research. The acc provides professional education and operates national registries for the me...

Is PCI Safe, Effective After Clot-Busters for Heart Attack?

...ons. The College is a leader in the formulation of health policy, standards and guidelines, and is a staunch supporter of cardiovascular research. The acc provides professional education and operates national registries for the measurement and improvement of quality care. ...

Filter Fails to Improve PCI Outcomes in Acute Coronary Syndromes

...ons. The College is a leader in the formulation of health policy, standards and guidelines, and is a staunch supporter of cardiovascular research. The acc provides professional education and operates national registries for the measurement and improvement of quality care. ...

Drug-Eluting Stents Outperform Bare Stents in Heart Attack

...l Trials session at the SCAI Annual Scientific Sessions in Partnership with acc i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for p... and guidelines, and is a staunch supporter of cardiovascular research. The acc provides professional education and operates national registries for the me...

BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack

...l Trials session at the SCAI Annual Scientific Sessions in Partnership with acc i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for p... and guidelines, and is a staunch supporter of cardiovascular research. The acc provides professional education and operates national registries for the me...

Tailored Clopidogrel Dosing Improves PCI Outcomes

...l Trials session at the SCAI Annual Scientific Sessions in Partnership with acc i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for p... and guidelines, and is a staunch supporter of cardiovascular research. The acc provides professional education and operates national registries for the me...

TRITON-TIMI 38 Stent Analysis Favors Prasugrel

...l Trials session at the SCAI Annual Scientific Sessions in Partnership with acc i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for p... and guidelines, and is a staunch supporter of cardiovascular research. The acc provides professional education and operates national registries for the me...

Study Finds Repeated Episodes of Stent Thrombosis Common

...l Trials session at the SCAI Annual Scientific Sessions in Partnership with acc i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for p... and guidelines, and is a staunch supporter of cardiovascular research. The acc provides professional education and operates national registries for the me...

Study Finds PCI Safe, Effective Despite Off-Site Cardiac Surgery

...CAI Annual Scientific Sessions in Partnership with acc i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a...s analyzed data from the NCDR CathPCI Registry (an acc initiative conducted in partnership with SCAI) on ... staunch supporter of cardiovascular research. The acc provides professional education and operates natio...

Stenting Techniques Vie in Branchpoint Lesions

...l Trials session at the SCAI Annual Scientific Sessions in Partnership with acc i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for p... and guidelines, and is a staunch supporter of cardiovascular research. The acc provides professional education and operates national registries for the me...

ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI

...l Trials session at the SCAI Annual Scientific Sessions in Partnership with acc i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for p... and guidelines, and is a staunch supporter of cardiovascular research. The acc provides professional education and operates national registries for the me...

Reduced Lung Capacity Accelerates With Diabetes

... Makers of Inhaled Insulin Should Take Note, Researchers Say Also: acc and ADA Release New Consensus Statement on Controlling Cardiometabolic Risk ALEXANDRIA, Va., March 27 /PRNewswire-USNewswire/ -- People who have d...

ImpactRx Tracks Decline in Zetia and Vytorin Prescribing

... Changes in prescribing behavior appear inconsistent with acc statements on ENHANCE study results MOUNT LAUREL, N.J., Jan. 24 /PRNewswire/ -- ImpactRx, Inc., the pioneering force in meas...

News from the American Heart Association

...can Heart Association meetings, privileges to the password-protected newsroom and the ability to receive advance materials. CONTACT: Amy Murphy: acc (202) 375-6476; amurphy@acc.org Cathy Lewis: AHA (214) 706-1324; cathy.lewis@heart.org New guidelines address care, treatment for heart atta...

New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease

...eca-us.com . Subscribe to AstraZeneca's RSS feed at: http://www.astrazeneca-us.com/subscribe_RSS.asp . (1) Reference Original METEOR Abstract from acc (2) Reference METEOR Abstract 1 ...

Despite Serious Health Risks, One in Three Adults with Heart Disease Does Not Believe They Need a Flu Shot This Year

...r serious flu-related complications, including people who suffer from heart disease, get vaccinated to protect against the flu every year. The AHA and acc recognize the value of flu shots as part of complete care for patients with heart disease and have issued an advisory urging all cardiologists to make...

ACC Concerned Over Reporting of Biomonitoring Results

...actually do just the opposite. Also of concern to acc and thousands of medical doctors and research scie...is a fundamental responsibility we take seriously. acc members meet this responsibility through complianc...ng companies engaged in the business of chemistry. acc members apply the science of chemistry to make inn...

ECLIPSE Data on Effects of Otsuka's Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients' Hemodynamics and Urine Output Featured in Heart Failure Society of America's Late Breaking Trials

...d indirect U.S. health care expenses related to HF tally about $28 billion, acc estimates. The majority of patients hospitalized for ADHF, the worsening of... of the European Society of Cardiology in Vienna, September 2003. (2) acc News Release, ''American College of Cardiology / American Heart Associ...

Cholesterol Drug Fails to Slow Progression of Coronary Disease, Cleveland Clinic Study Reports

...e through education, research, promotion, development and application of standards and guidelines- and to influence health care policy. ACC.07 and the acc inaugural i2 Summit, the first-ever meeting for interventional cardiologists, will bring together more than 30,000 cardiologists and cardiovascular sp...

Everest Data on Short- and Long-Term Use of Otsuka's Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACC's Late Breaking Clinical Trials

...re expenses related to HF tally about $28 billion, acc estimates.(5) The majority of patients hospitalize...linical Status Trials." JAMA 2007;297:1332-1343. acc Presentation: 402-7 Session: ACC.07 Late-Breakin...of Cardiology in Vienna, September 2003. (7) acc News Release, " of Cardiology / American Heart ...

Abbott's Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial

...ts in Europe, Asia-Pacific, Canada and Latin America. For images of Abbott's XIENCE V stent and other information, please visit the company's online acc newsroom at http://www.abbottvascular.com/ACCpresskit . About Abbott Vascular...
Other Tags
(Date:3/12/2015)... VIEW, Calif. , March 12, 2015 /PRNewswire/ ... with Complimentary Registration here: http://bit.ly/1G7Os0L . SPEAKERS: ... Manager Aravind SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 ... in order to compete in several different markets ... market is currently witnessing an uptrend. ...
(Date:3/10/2015)... , March 10, 2015  Continuing its 167-year history ... Hammacher Schlemmer introduces The Eye Scanning Password Authenticator ... granting access to secure websites or sensitive data. ... travelers at international borders, the device has a small ... points of the iris, converting them into an encrypted ...
(Date:3/10/2015)... OXFORD, Conn. , March 10, 2015 /PRNewswire/ ... NXTDW) ("NXT-ID" or the "Company"), a biometric authentication ... reports the company,s Wocket™ smart wallet has been ... 2015" by Rethink Modern. Rethink Modern ... sharing modern and innovative items for your home and lifestyle that ...
Breaking Biology News(10 mins):Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4
(Date:3/28/2015)... York, NY (PRWEB) March 28, 2015 ... that offers urgent care in Manhattan, recently commemorated its ... care facility in Manhattan. In addition to 24-hour urgent ... ER facilities. , At this time, Emergency Medical ... for abdominal pain, asthma, chest pain, eye injuries, ear ...
(Date:3/28/2015)... March 28, 2015 An article in ... which could prove critical to organizations that deal with ... critical aspect of data security, is worsening . ... security report, every major category out of the twelve ... testing. “With all the craziness that has gone on ...
(Date:3/28/2015)... Pitching speed, player’s height, and pitching for multiple ... injuries, according to new research released today at the American ... , “Our findings indicate that a 10 inch increase in ... a history of injury, a 10 mile per hour increase ... a history of injury, and playing for more than one ...
(Date:3/28/2015)... How best to treat and recover ... orthopaedic medicine. While diagnostic hip injections are commonly performed ... etiology, research presented today at the American Orthopaedic Society ... that pain relief from this diagnostic injection may not ... “Our study looked to assess if the amount of ...
(Date:3/28/2015)... (PRWEB) March 28, 2015 Early surgery ... with Type V AC joint injuries, according to new ... today at the American Orthopaedic Society for Sports Medicine’s ... to duty faster when surgery was not performed. , ... 7 receiving surgical treatment and 17 receiving non-surgical therapy. ...
Breaking Medicine News(10 mins):Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:For Type V AC Joint Injuries, Early Surgery May Not Be the Best Approach 2
Other Contents